{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:23:18Z","timestamp":1794489798379,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171792"],"award-info":[{"award-number":["82171792"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370299"],"award-info":[{"award-number":["82370299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200429"],"award-info":[{"award-number":["82200429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010229","name":"Natural Science Foundation of Tianjin Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["23JCYBJC00280"],"award-info":[{"award-number":["23JCYBJC00280"]}],"id":[{"id":"10.13039\/501100010229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Myocardial infarction (MI) remains one of the leading causes of mortality worldwide, and cardiomyocyte death plays a critical role in cardiac remodeling after MI. Ferroptosis is a recently identified form of iron-dependent programmed cell death that has been shown to be involved in the progression of various cardiovascular diseases, including MI. Bromodomain-containing protein 4 (BRD4) is an epigenetic reader and a key regulator of cell survival. In this study, we screened an epigenetic target library containing 773 small-molecule compounds and found that (+)-JQ-1(hereafter abbreviated as JQ-1), a BRD4-specific inhibitor, markedly attenuated ferroptosis induced by erastin (a ferroptosis inducer) in cardiomyocytes. Both prophylactic and therapeutic JQ-1 administration significantly improved cardiac remodeling and reduced cardiomyocyte ferroptosis in mice with MI. Mechanistically, JQ-1 protected cardiomyocytes from erastin-induced ferroptosis by downregulating the expression of nicotinate phosphoribosyltransferase (NAPRT) and upregulating the expression of nicotinamide phosphoribosyltransferase (NAMPT) and sirtuin1 (SIRT1). Inhibition of NAMPT or SIRT1 abrogated the protection conferred by JQ-1 in erastin-treated H9C2 cardiomyocytes. The combination of proteolysis-targeting chimeras (PROTACs) with JQ-1 (JQ-1-PROTAC) promoted BRD4 protein degradation and rescued erastin-induced ferroptosis in H9C2 cardiomyocytes, and prevented erastin-induced ferroptosis in human cardiomyocytes. Thus, JQ-1 can protect cardiomyocytes from ferroptosis through the NAMPT-SIRT1 pathway, and JQ-1-based therapy may serve as a novel promising strategy to improve cardiac remodeling after MI.<\/jats:p>","DOI":"10.1038\/s41419-025-07880-x","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:47:14Z","timestamp":1753231634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["(+)-JQ-1 alleviates cardiac injury in myocardial infarction by inhibiting ferroptosis through the NAMPT\/SIRT1 pathway"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9327-2666","authenticated-orcid":false,"given":"Mengxue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinna","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5924-9738","authenticated-orcid":false,"given":"Huabing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0040-4470","authenticated-orcid":false,"given":"Shengkai","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"7880_CR1","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJMra2030281","volume":"385","author":"S Rajagopalan","year":"2021","unstructured":"Rajagopalan S, Landrigan PJ. Pollution and the heart. N Engl J Med. 2021;385:1881\u201392.","journal-title":"N Engl J Med"},{"key":"7880_CR2","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2024;149:e347\u2013913.","journal-title":"Circulation"},{"key":"7880_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1161\/CIRCULATIONAHA.119.045566","volume":"142","author":"LJ He","year":"2020","unstructured":"He LJ, Nguyen NB, Ardehali R, Zhou B. Heart regeneration by endogenous stem cells and cardiomyocyte proliferation controversy, fallacy, and progress. Circulation. 2020;142:275\u201391.","journal-title":"Circulation"},{"key":"7880_CR4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020;17:773\u201389.","journal-title":"Nat Rev Cardiol"},{"key":"7880_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102629","volume":"104","author":"LL Zhu","year":"2025","unstructured":"Zhu LL, Liu YY, Wang KK, Wang N. Regulated cell death in acute myocardial infarction: Molecular mechanisms and therapeutic implications. Ageing Res Rev. 2025;104:102629.","journal-title":"Ageing Res Rev"},{"key":"7880_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10495-025-02075-3","volume":"30","author":"H Wu","year":"2025","unstructured":"Wu H, Lan Q, He YX, Xue JY, Liu H, Zou Y, et al. Programmed cardiomyocyte death in myocardial infarction. Apoptosis. 2025;30:597\u2013615.","journal-title":"Apoptosis"},{"key":"7880_CR7","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"XX Fang","year":"2019","unstructured":"Fang XX, Wang H, Han D, Xie EJ, Yang X, Wei JY, et al. Ferroptosis as a target for protection against cardiomyopathy. P Natl Acad Sci USA. 2019;116:2672\u201380.","journal-title":"P Natl Acad Sci USA"},{"key":"7880_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107281","volume":"206","author":"KX Cai","year":"2024","unstructured":"Cai KX, Jiang HY, Zou YM, Song CY, Cao KX, Chen SX, et al. Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches. Pharm Res. 2024;206:107281.","journal-title":"Pharm Res"},{"key":"7880_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2061-8","volume":"10","author":"TJ Park","year":"2019","unstructured":"Park TJ, Park JH, Lee GS, Lee JY, Shin JH, Kim MW, et al. Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes. Cell Death Dis. 2019;10:835.","journal-title":"Cell Death Dis"},{"key":"7880_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305895","volume":"11","author":"QB Lv","year":"2024","unstructured":"Lv QB, Lin J, Huang H, Ma BX, Li WJ, Chen JW, et al. Nanosponge for iron chelation and efflux: a ferroptosis-inhibiting approach for myocardial infarction therapy. Adv Sci. 2024;11:e2305895.","journal-title":"Adv Sci"},{"key":"7880_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fonc.2020.00358","volume":"10","author":"V Audrito","year":"2020","unstructured":"Audrito V, Messana VG, Deaglio S. NAMPT and NAPRT: two metabolic enzymes with key roles in inflammation. Front Oncol. 2020;10:358.","journal-title":"Front Oncol"},{"key":"7880_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/dom.12171","volume":"15","author":"S Imai","year":"2013","unstructured":"Imai S, Yoshino J. The importance of NAMPT\/NAD\/SIRT1 in the systemic regulation of metabolism and ageing. Diab Obes Metab. 2013;15:26\u201333.","journal-title":"Diab Obes Metab"},{"key":"7880_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12929-023-00927-1","volume":"30","author":"J Ju","year":"2023","unstructured":"Ju J, Li XM, Zhao XM, Li FH, Wang SC, Wang K, et al. Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia\/reperfusion injury by interacting with NAMPT. J Biomed Sci. 2023;30:45.","journal-title":"J Biomed Sci"},{"key":"7880_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.906073","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang MM, Qin CS, Wang ZK, Chen JH, Wang R, et al. Resveratrol attenuate myocardial injury by inhibiting ferroptosis inducing KAT5\/GPX4 in myocardial infarction. Front Pharm. 2022;13:906073.","journal-title":"Front Pharm"},{"key":"7880_CR15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJMra1402513","volume":"378","author":"AP Feinberg","year":"2018","unstructured":"Feinberg AP. The key role of epigenetics in human disease prevention and mitigation. N Engl J Med. 2018;378:1323\u201334.","journal-title":"N Engl J Med"},{"key":"7880_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"DL Tang","year":"2021","unstructured":"Tang DL, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"7880_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","volume":"154","author":"P Anand","year":"2013","unstructured":"Anand P, Brown JD, Lin CY, Qi J, Zhang RL, Artero PC, et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell. 2013;154:569\u201382.","journal-title":"Cell"},{"key":"7880_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah5084","volume":"9","author":"QM Duan","year":"2017","unstructured":"Duan QM, McMahon S, Anand P, Shah H, Thomas S, Salunga HT, et al. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure. Sci Transl Med. 2017;9:eaah5084.","journal-title":"Sci Transl Med"},{"key":"7880_CR19","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1161\/CIRCULATIONAHA.120.047753","volume":"142","author":"A Padmanabhan","year":"2020","unstructured":"Padmanabhan A, Alexanian M, Linares-Saldana R, Gonz\u00e1lez-Ter\u00e1n B, Andreoletti G, Huang Y, et al. BRD4 (Bromodomain-Containing Protein 4) Interacts with GATA4 (GATA Binding Protein 4) to Govern Mitochondrial Homeostasis in Adult Cardiomyocytes. Circulation. 2020;142:2338\u201355.","journal-title":"Circulation"},{"key":"7880_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/FJC.0000000000001138","volume":"78","author":"HW Wei","year":"2021","unstructured":"Wei HW, Xue QJ, Sun L, Lv J. BRD4 inhibition protects against myocardial ischemia\/reperfusion injury by suppressing inflammation and oxidative stress through the PI3K\/AKT signaling pathway. J Cardiovasc Pharm. 2021;78:839\u201346.","journal-title":"J Cardiovasc Pharm"},{"key":"7880_CR21","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3892\/etm.2015.2789","volume":"10","author":"YL Sun","year":"2015","unstructured":"Sun YL, Huang J, Song KP. BET protein inhibition mitigates acute myocardial infarction damage in rats via the TLR4\/TRAF6\/NF-\u03baB pathway. Exp Ther Med. 2015;10:2319\u201324.","journal-title":"Exp Ther Med"},{"key":"7880_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1755-5922.12320","volume":"36","author":"YP Sun","year":"2018","unstructured":"Sun YP, Xie Y, Du LP, Sun JW, Liu ZQ. Inhibition of BRD4 attenuates cardiomyocyte apoptosis via NF-B pathway in a rat model of myocardial infarction. Cardiovasc Ther. 2018;36:1\u20138.","journal-title":"Cardiovasc Ther"},{"key":"7880_CR23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","volume":"107","author":"E Gao","year":"2010","unstructured":"Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circulation Res. 2010;107:1445\u201353.","journal-title":"Circulation Res"},{"key":"7880_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","volume":"132","author":"B Ye","year":"2023","unstructured":"Ye B, Zhou H, Chen Y, Luo W, Lin W, Zhao Y, et al. USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes. Circulation Res. 2023;132:465\u201380.","journal-title":"Circulation Res"},{"key":"7880_CR25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1158\/2326-6066.CIR-19-0159","volume":"8","author":"JY Liang","year":"2020","unstructured":"Liang JY, Wang LL, Wang C, Shen JF, Su BJ, Marisetty AL, et al. Verteporfin inhibits PD-L1 through autophagy and the STAT1-IRF1-TRIM28 signaling axis, exerting antitumor efficacy. Cancer Immunol Res. 2020;8:952\u201365.","journal-title":"Cancer Immunol Res"},{"key":"7880_CR26","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1161\/01.CIR.0000034049.61181.F3","volume":"106","author":"R Liao","year":"2002","unstructured":"Liao R, Jain M, Cui L, D\u2019Agostino J, Aiello F, Luptak I, et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation. 2002;106:2125\u201331.","journal-title":"Circulation"},{"key":"7880_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jacbts.2023.08.013","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Sandroni PB, Huang W, Gao X, Oswalt L, Schroder MA, et al. Cardiomyocyte alpha-1A adrenergic receptors mitigate postinfarct remodeling and mortality by constraining necroptosis. JACC Basic Transl Sci. 2024;9:78\u201396.","journal-title":"JACC Basic Transl Sci"},{"key":"7880_CR28","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","volume":"146","author":"L Jin","year":"2022","unstructured":"Jin L, Geng L, Ying L, Shu L, Ye K, Yang R, et al. FGF21-sirtuin 3 axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity. Circulation. 2022;146:1537\u201357.","journal-title":"Circulation"},{"key":"7880_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1226044","volume":"11","author":"HT Endale","year":"2023","unstructured":"Endale HT, Tesfaye W, Mengstie TA. ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol. 2023;11:1226044.","journal-title":"Front Cell Dev Biol"},{"key":"7880_CR30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.freeradbiomed.2017.08.008","volume":"112","author":"D Giustarini","year":"2017","unstructured":"Giustarini D, Colombo G, Garavaglia ML, Astori E, Portinaro NM, Reggiani F, et al. Assessment of glutathione\/glutathione disulphide ratio and -glutathionylated proteins in human blood, solid tissues, and cultured cells. Free Radic Bio Med. 2017;112:360\u201375.","journal-title":"Free Radic Bio Med"},{"key":"7880_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tcb.2023.06.002","volume":"34","author":"S Ahola","year":"2024","unstructured":"Ahola S, Langer T. Ferroptosis in mitochondrial cardiomyopathy. Trends Cell Biol. 2024;34:150\u201360.","journal-title":"Trends Cell Biol"},{"key":"7880_CR32","doi-asserted-by":"publisher","first-page":"12846","DOI":"10.3390\/ijms241612846","volume":"24","author":"J Laukaitiene","year":"2023","unstructured":"Laukaitiene J, Gujyte G, Kadusevicius E. Cardiomyocyte Damage: Ferroptosis Relation to Ischemia-Reperfusion Injury and Future Treatment Options. Int J Mol Sci. 2023;24:12846.","journal-title":"Int J Mol Sci"},{"key":"7880_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110469","volume":"377","author":"WQ Wang","year":"2023","unstructured":"Wang WQ, Zhong X, Fang ZM, Li JM, Li HB, Liu XS, et al. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2\/Keap1 pathway. Chem-Biol Interact. 2023;377:110469.","journal-title":"Chem-Biol Interact"},{"key":"7880_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1525294","volume":"13","author":"YM Zhang","year":"2025","unstructured":"Zhang YM, Kong FX, Li N, Tao LN, Zhai JH, Ma J, et al. Potential role of SIRT1 in cell ferroptosis. Front Cell Dev Biol. 2025;13:1525294.","journal-title":"Front Cell Dev Biol"},{"key":"7880_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","volume":"22","author":"AJ Covarrubias","year":"2021","unstructured":"Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD: metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Bio. 2021;22:119\u201341.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"7880_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.853652","volume":"10","author":"CH Lin","year":"2022","unstructured":"Lin CH, Kuo JCT, Li D, Koenig AB, Pan A, Yan P, et al. AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells. Front Cell Dev Biol. 2022;10:853652.","journal-title":"Front Cell Dev Biol"},{"key":"7880_CR37","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1039\/D1CS00762A","volume":"51","author":"Y Chen","year":"2022","unstructured":"Chen Y, Tandon I, Heelan W, Wang YX, Tang WP, Hu QY. Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation. Chem Soc Rev. 2022;51:5330\u201350.","journal-title":"Chem Soc Rev"},{"key":"7880_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106793","volume":"140","author":"HL Fan","year":"2023","unstructured":"Fan HL, Zhou ZL, Yu DH, Sun J, Wang L, Jia YY, et al. Selective degradation of BRD4 suppresses lung cancer cell proliferation using GSH-responsive PROTAC precursors. Bioorg Chem. 2023;140:106793.","journal-title":"Bioorg Chem"},{"key":"7880_CR39","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, et al. Selective inhibition of BET bromodomains. Nature. 2010;468:1067\u201373.","journal-title":"Nature"},{"key":"7880_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.609319","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Zhong XL, Cao WY, Mao ML, Li W, Yang H, et al. JQ1 as a BRD4 inhibitor blocks inflammatory pyroptosis-related acute colon injury induced by LPS. Front Immunol. 2021;12:609319.","journal-title":"Front Immunol"},{"key":"7880_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.642294","volume":"12","author":"N Wang","year":"2021","unstructured":"Wang N, Wu RL, Comish PB, Kang R, Tang DL. Pharmacological modulation of BET family in sepsis. Front Pharm. 2021;12:642294.","journal-title":"Front Pharm"},{"key":"7880_CR42","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.7150\/jca.69375","volume":"13","author":"HJ Wang","year":"2022","unstructured":"Wang HJ, Liu GY, Jin XH, Song SL, Chen SY, Zhou PQ, et al. BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC. J Cancer. 2022;13:2126\u201337.","journal-title":"J Cancer"},{"key":"7880_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1564-7","volume":"10","author":"SY Sui","year":"2019","unstructured":"Sui SY, Zhang J, Xu SP, Wang Q, Wang PY, Pang D. Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells. Cell Death Dis. 2019;10:331.","journal-title":"Cell Death Dis"},{"key":"7880_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12672-024-00928-y","volume":"15","author":"CY Fan","year":"2024","unstructured":"Fan CY, Guo XH, Zhang J, Zheng W, Shi CL, Qin YW, et al. BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1. Discov Oncol. 2024;15:98.","journal-title":"Discov Oncol"},{"key":"7880_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05344-0","volume":"13","author":"MH Yang","year":"2022","unstructured":"Yang MH, Liu K, Chen P, Zhu HY, Wang JJ, Huang J. Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis. Cell Death Dis. 2022;13:912.","journal-title":"Cell Death Dis"},{"key":"7880_CR46","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s13770-021-00346-z","volume":"18","author":"S Go","year":"2021","unstructured":"Go S, Kang MY, Kwon SP, Jung MY, Jeon OH, Kim BS. The senolytic drug JQ1 removes senescent cells via ferroptosis. Tissue Eng Regen Med. 2021;18:841\u201350.","journal-title":"Tissue Eng Regen Med"},{"key":"7880_CR47","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1161\/CIRCRESAHA.120.315929","volume":"126","author":"PC Borck","year":"2020","unstructured":"Borck PC, Guo LW, Plutzky J. BET epigenetic reader proteins in cardiovascular transcriptional programs. Circ Res. 2020;126:1190\u2013208.","journal-title":"Circ Res"},{"key":"7880_CR48","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.ebiom.2015.09.045","volume":"2","author":"BW Wang","year":"2015","unstructured":"Wang BW, Zhang MX, Takayama T, Shi XD, Roenneburg DA, Kent KC, et al. BET Bromodomain blockade mitigates intimal hyperplasia in rat carotid arteries. Ebiomedicine. 2015;2:1650\u201361.","journal-title":"Ebiomedicine"},{"key":"7880_CR49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.molcel.2014.08.024","volume":"56","author":"JD Brown","year":"2014","unstructured":"Brown JD, Lin CY, Duan Q, Griffin G, Federation AJ, Paranal RM, et al. NF-\u03baB Directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell. 2014;56:219\u201331.","journal-title":"Mol Cell"},{"key":"7880_CR50","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1172\/JCI135922","volume":"130","author":"G Auguste","year":"2020","unstructured":"Auguste G, Rouhi L, Matkovich SJ, Coarfa C, Robertson MJ, Czernuszewicz G, et al. BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A\/C deficient mice. J Clin Invest. 2020;130:4740\u201358.","journal-title":"J Clin Invest"},{"key":"7880_CR51","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.116.022495","volume":"134","author":"CF Lee","year":"2016","unstructured":"Lee CF, Chavez JD, Garcia-Menendez L, Choi Y, Roe ND, Chiao YA, et al. Normalization of NAD redox balance as a therapy for heart failure. Circulation. 2016;134:883\u201394.","journal-title":"Circulation"},{"key":"7880_CR52","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","volume":"100","author":"RR Alcendor","year":"2007","unstructured":"Alcendor RR, Gao SM, Zhai PY, Zablocki D, Holle E, Yu XZ, et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res. 2007;100:1512\u201321.","journal-title":"Circ Res"},{"key":"7880_CR53","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.121.056589","volume":"144","author":"M Abdellatif","year":"2021","unstructured":"Abdellatif M, Sedej S, Kroemer G. NAD+ metabolism in cardiac health, aging, and disease. Circulation. 2021;144:1795\u2013817.","journal-title":"Circulation"},{"key":"7880_CR54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1161\/CIRCRESAHA.109.203703","volume":"105","author":"CP Hsu","year":"2009","unstructured":"Hsu CP, Oka S, Shao D, Hariharan N, Sadoshima J. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res. 2009;105:481\u201391.","journal-title":"Circ Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07880-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07880-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07880-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:15:19Z","timestamp":1757279719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07880-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7880"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07880-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods in this study were performed in accordance with the relevant guidelines and regulations. All animal protocols and experiments were approved by the Animal Care and Use Committee of Tianjin Medical University (TMUaMEC 2022036).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"548"}}